This study developed an InnoPrimers-duplex qPCR for detection of NPC blood circulating LMP1 30 bp deletion genetic biomarker for early diagnosis and treatment response prediction of NPC patients. The gene discussed is PDLIM7; the disease is nasopharyngeal carcinoma.